Sign up now with your company or organization email and enjoy a
1-week free trial!
Contract Details
| Title |
Conclusion of Indication-restricted Non-exclusive Discount Contracts Pursuant to Section 130a (8) Sgb V for Medicaments with the Active Substance Everolimus (atc: L01xe10) - Patent-free Indications - open-house Model Germany |
|||
|---|---|---|---|---|
You can sign up and unlock it for freeAccess to Public and Private Sector Business Opportunities for 200+ Countries |
||||
| Country | ||||
| Language | English | |||
| Organization | ||||
| Published Date | 06.02.2024 | |||
| Awarded Date | 22.04.2021 | |||
| Overview | Contract Award's Details : Conclusion of Indication-restricted Non-exclusive Discount Contracts Pursuant to Section 130a (8) Sgb V for Medicaments with the Active Substance Everolimus (atc: L01xe10) - Patent-free Indications - open-house Model AOK -RHINELAND-PALATINATE / SAARLAND -THE HEALTH INSURANCE Conclusion of Indication-restricted Non-exclusive Discount Contracts Pursuant to Section 130a (8) Sgb V for Medicaments with the Active Substance Everolimus (atc: L01xe10) - Patent-free Indications - open-house Model Document Type: Contract Award Notice Title: Conclusion of indication-restricted non-exclusive discount contracts pursuant to ? 130a (8) SGB V to drugs with the active substance Everolimus (ATC: L01XE10) - Patent-free indications - Open-House model Reference Number: 2021 / S 065-165046 Contract Type: Supplies Estimated Value: 0.01 - EUR DESCRIPTION: CONTRIBUTION Indication-restricted non-exclusive discount contracts pursuant to Section 130a (8) SGB V for medicaments with the Everolimus active substance (ATC code: L01XE10) - Patent-free indications - within the period from 1.4.2021 to 31.3.2023 with any possibility of the conclusion of the contract ( Open-House model). 33600000 - Pharmaceutical Products Authority Type: Body Governed by Public Law Type of Procedure: Open Procedure Regulation: European Union Bid Type: Not Applicable Doc Title: Pharmaceutical Products Dispatch Date: 2021-03-31 Publish Date: 2021-04-02 Germany Contract value : 0.01 EUR Contractors : HEUMANN PHARMA GMBH 10/03/2021 23/04/2021 See in details 77224273 23/04/2021 AOK -RHINELAND-PALATINATE / SAARLAND -THE HEALTH INSURANCE Address : Address : Virchowstra e 30 Town : Eisenberg NUTS-Code : DE - Deutschland Postal Code : 67304 Contact Point : Kerstin Blasius Phone : +49 6351403363 www.aok.de/rheinland-pfalz-saarland/ am_vertraege@rps.aok.de Germany Germany Contract Awards Germany 10/03/2021 See in details 0.01 EUR | |||
| NAICS | ||||
| CPVS | ||||
| UNSPSC |
-
|
|||
| Regions | ||||
| Sectors | ||||
| Contractor | ||||
| Contract Value |
0.01 EUR
|
URL | ||
| Share | ||||
Germany
| Title |
|---|
Conclusion of Indication-restricted Non-exclusive Discount Contracts Pursuant to Section 130a (8) Sgb V for Medicaments with the Active Substance Everolimus (atc: L01xe10) - Patent-free Indications - open-house Model Germany |
| Country |
| Language |
| English |
| Organization |
| Published Date |
| 06.02.2024 |
| Awarded Date |
| 22.04.2021 |
| Overview |
| Contract Award's Details : Conclusion of Indication-restricted Non-exclusive Discount Contracts Pursuant to Section 130a (8) Sgb V for Medicaments with the Active Substance Everolimus (atc: L01xe10) - Patent-free Indications - open-house Model AOK -RHINELAND-PALATINATE / SAARLAND -THE HEALTH INSURANCE Conclusion of Indication-restricted Non-exclusive Discount Contracts Pursuant to Section 130a (8) Sgb V for Medicaments with the Active Substance Everolimus (atc: L01xe10) - Patent-free Indications - open-house Model Document Type: Contract Award Notice Title: Conclusion of indication-restricted non-exclusive discount contracts pursuant to ? 130a (8) SGB V to drugs with the active substance Everolimus (ATC: L01XE10) - Patent-free indications - Open-House model Reference Number: 2021 / S 065-165046 Contract Type: Supplies Estimated Value: 0.01 - EUR DESCRIPTION: CONTRIBUTION Indication-restricted non-exclusive discount contracts pursuant to Section 130a (8) SGB V for medicaments with the Everolimus active substance (ATC code: L01XE10) - Patent-free indications - within the period from 1.4.2021 to 31.3.2023 with any possibility of the conclusion of the contract ( Open-House model). 33600000 - Pharmaceutical Products Authority Type: Body Governed by Public Law Type of Procedure: Open Procedure Regulation: European Union Bid Type: Not Applicable Doc Title: Pharmaceutical Products Dispatch Date: 2021-03-31 Publish Date: 2021-04-02 Germany Contract value : 0.01 EUR Contractors : HEUMANN PHARMA GMBH 10/03/2021 23/04/2021 See in details 77224273 23/04/2021 AOK -RHINELAND-PALATINATE / SAARLAND -THE HEALTH INSURANCE Address : Address : Virchowstra e 30 Town : Eisenberg NUTS-Code : DE - Deutschland Postal Code : 67304 Contact Point : Kerstin Blasius Phone : +49 6351403363 www.aok.de/rheinland-pfalz-saarland/ am_vertraege@rps.aok.de Germany Germany Contract Awards Germany 10/03/2021 See in details 0.01 EUR |
| NAICS |
| Other Direct Insurance (except Life Justice Regulation Justice Other Justice Regulation Direct Insurance (except Life Direct Life Other Justice |
| CPVS |
| Sections Postal orders Dates |
| UNSPSC |
| - |
| Regions |
| Europe Western Europe |
| Sectors |
| Healthcare and Medicine Automobiles and Auto Parts Supply Postal and Courier Services Law and Legal Printing and Publishing Electricity Construction Energy-Power and Electrical Computer Hardwares and Consumables Steel Pharmaceuticals |
| Contractor |
| Contract Value |
|
0.01 EUR
|
| URL |
|
|
| Share |
To be notified
when a tender matching your filter is
published
To Follow
Tenders
Add New Tender Alert
To Follow
Contracts
Add New Contract Alert
To Follow
Fairs
Add New Fair Alert
Similar Contracts